BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 34679269)

  • 1. [Retroviral restriction factors : from Fv1 to TRIM5α].
    Cissé A; Darbandi-Tehrani K; Derache A; El Houry S; Marlin R; Pernet O; Nisole S
    Virologie (Montrouge); 2006 Apr; 10(2):119-127. PubMed ID: 34679269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
    Oliveira NM; Trikha R; McKnight Á
    Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
    Ulm JW; Perron M; Sodroski J; C Mulligan R
    Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
    Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
    Yap MW; Nisole S; Stoye JP
    Curr Biol; 2005 Jan; 15(1):73-8. PubMed ID: 15649369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins.
    Saenz DT; Teo W; Olsen JC; Poeschla EM
    J Virol; 2005 Dec; 79(24):15175-88. PubMed ID: 16306589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Human TRIM5α in Intrinsic Immunity.
    Nakayama EE; Shioda T
    Front Microbiol; 2012; 3():97. PubMed ID: 22435067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of Fv1: effects on retroviral restriction specificities.
    Li W; Yap MW; Voss V; Stoye JP
    Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction factors: a defense against retroviral infection.
    Bieniasz PD
    Trends Microbiol; 2003 Jun; 11(6):286-91. PubMed ID: 12823946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction of multiple divergent retroviruses by Lv1 and Ref1.
    Hatziioannou T; Cowan S; Goff SP; Bieniasz PD; Towers GJ
    EMBO J; 2003 Feb; 22(3):385-94. PubMed ID: 12554640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races.
    Tenthorey JL; Young C; Sodeinde A; Emerman M; Malik HS
    Elife; 2020 Sep; 9():. PubMed ID: 32930662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.
    Keckesova Z; Ylinen LM; Towers GJ
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10780-5. PubMed ID: 15249687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-entry restriction of retroviral infections.
    Towers GJ; Goff SP
    AIDS Rev; 2003; 5(3):156-64. PubMed ID: 14598564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
    Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
    J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses.
    Yap MW; Colbeck E; Ellis SA; Stoye JP
    PLoS Pathog; 2014 Mar; 10(3):e1003968. PubMed ID: 24603659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses.
    Schaller T; Ylinen LM; Webb BL; Singh S; Towers GJ
    J Virol; 2007 Sep; 81(18):10055-63. PubMed ID: 17609268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells.
    Bérubé J; Bouchard A; Berthoux L
    Retrovirology; 2007 Sep; 4():68. PubMed ID: 17892575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
    Passerini LD; Keckesova Z; Towers GJ
    J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.
    Pawlica P; Le Sage V; Poccardi N; Tremblay MJ; Mouland AJ; Berthoux L
    J Virol; 2014 May; 88(10):5661-76. PubMed ID: 24600008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
    Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
    J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.